Wechsler, Shamsah Kazani, and Gautham Marigowda
Additionally, adaptive platform trials could enable simultaneous evaluation of multiple candidate interventions, accelerating the identification of the most promising regimens
The FDA recently approved Semaglutide as a prescription weight loss aid
But right now, patients should understand the difference between exciting trial news and treatment that is already part of standard care
An InBody scan records your starting lean mass and fat mass so later changes can be measured rather than estimated
The article explains that transdermal estradiol patches bypass hepatic first-pass processing, which reduces changes to lipids and clotting factors compared with oral estrogen, so the transdermal route generally pairs more safely with GLP-1 medications